CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-10 | Green Kevin Dennis Chief Financial Officer | Exercise or conversion | +6,000 | 54,405 | ||
| 2017-03-10 | Green Kevin Dennis Chief Financial Officer | Exercise or conversion · Restricted Stock Unit | −6,000 | 12,000 | ||
| 2017-03-10 | CORASH LAURENCE M Chief Scientific Officer | Exercise or conversion | +6,000 | 1,328,945 | ||
| 2017-03-10 | CORASH LAURENCE M Chief Scientific Officer | Exercise or conversion · Restricted Stock Unit | −6,000 | 12,000 | ||
| 2017-03-10 | Benjamin Richard J Chief Medical Officer | Exercise or conversion | +3,000 | 3,000 | ||
| 2017-03-10 | Benjamin Richard J Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −3,000 | 6,000 | ||
| 2017-03-01 | Jayaraman Vivek K Chief Commercial Officer | Grant or award · Option (Right to Buy) | +50,000 | 50,000 | ||
| 2017-03-01 | Jayaraman Vivek K Chief Commercial Officer | Grant or award · Restricted Stock Unit | +11,250 | 11,250 | ||
| 2017-03-01 | Moore Carol SVP Reg. & Quality | Grant or award · Option (Right to Buy) | +100,000 | 100,000 | ||
| 2017-03-01 | Moore Carol SVP Reg. & Quality | Grant or award · Restricted Stock Unit | +22,500 | 22,500 | ||
| 2017-03-01 | Menard Chrystal Chief Legal Officer | Grant or award · Option (Right to Buy) | +100,000 | 100,000 | ||
| 2017-03-01 | Menard Chrystal Chief Legal Officer | Grant or award · Restricted Stock Unit | +22,500 | 22,500 | ||
| 2017-03-01 | Greenman William Mariner President and CEO | Grant or award · Option (Right to Buy) | +400,000 | 400,000 | ||
| 2017-03-01 | Greenman William Mariner President and CEO | Grant or award · Restricted Stock Unit | +84,375 | 84,375 | ||
| 2017-03-01 | Green Kevin Dennis Chief Financial Officer | Grant or award · Option (Right to Buy) | +100,000 | 100,000 | ||
| 2017-03-01 | Green Kevin Dennis Chief Financial Officer | Grant or award · Restricted Stock Unit | +22,500 | 22,500 | ||
| 2017-03-01 | CORASH LAURENCE M Chief Scientific Officer | Grant or award · Option (Right to Buy) | +100,000 | 100,000 | ||
| 2017-03-01 | CORASH LAURENCE M Chief Scientific Officer | Grant or award · Restricted Stock Unit | +22,500 | 22,500 | ||
| 2017-03-01 | Benjamin Richard J Chief Medical Officer | Grant or award · Option (Right to Buy) | +100,000 | 100,000 | ||
| 2017-03-01 | Benjamin Richard J Chief Medical Officer | Grant or award · Restricted Stock Unit | +22,500 | 22,500 |
Page 53 of 57 · 1,128 trades